|
CBM588 Capsules Clinical Trials
1 actively recruiting trial across 1 location
Also known as: C. butyricum MIYAIRI 588, C. butyricum strain MIYAIRI 588, CBM588, Clostridium butyricum MIYAIRI 588
Duarte, California1 trial
CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer
City of Hope Medical Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.